• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
Ding Yue-mei, Zhang Yao-quan, Zhang Tian-ying, Chai Lu, Hu Hong, Wang Bin. Relationship between serum fatty acid binding protein 4 and abdominal aortic calcification in peritoneal dialysis patients[J]. Journal of Clinical Nephrology, 2023, 23(3): 208-214. DOI: 10.3969/j.issn.1671-2390.2023.03.005
Citation: Ding Yue-mei, Zhang Yao-quan, Zhang Tian-ying, Chai Lu, Hu Hong, Wang Bin. Relationship between serum fatty acid binding protein 4 and abdominal aortic calcification in peritoneal dialysis patients[J]. Journal of Clinical Nephrology, 2023, 23(3): 208-214. DOI: 10.3969/j.issn.1671-2390.2023.03.005
shu

Relationship between serum fatty acid binding protein 4 and abdominal aortic calcification in peritoneal dialysis patients

  • Department of Nephrology, Affiliated Jiangyin Hospital, Southeast University School of Medicine, Jiangyin 214400, China

Funds: 

Jiangsu Province's Batch XV of "Six Talent Peaks" Grant for High-level Talent Selection & Training(WSN-040)

More Information
  • Received Date: April 23, 2022
  • Available Online: May 11, 2023
  • Published Date: March 27, 2023
    Graphical Abstract
    • Abstract
  • Objective To explore the relationship between serum level of fatty acid binding protein-4(FABP-4) and abdominal aortic calcification(AAC) in patients on peritoneal dialysis(PD).Methods From January 2020 to January 2022,a total of 108 hospitalized PD patients were recruited.There were 58 males and 50 females with an age of(57.2±4.9)(48-72) years.They were divided into two groups of low FABP-4 and high FABP-4 according to the median value of serum FABP-4.Also they were assigned into two groups of no-mild calcification(0-4 points,n=48) and moderate-severe calcification(＞4 points,n=60) according to AAC score.Results There were 54 patients with low FABP-4(＜148.6) and 54 with high FABP-4(4.6,178.9) μg/L.Univariate comparison showed that dialysis time of high FABP-4 group was longer,urea clearance rate was lower,the serum levels of high-sensitivity C-reactive protein(hs-CRP),creatinine,intact parathyroid hormone(iPTH) and alkaline phosphatase(ALP) were higher,body fat mass and percentage were higher and AAC score was higher than low FABP-4 group(P＜0.05).Spearman’s correlation analysis indicated that the level of FABP-4 was correlated positively with dialysis time,hs-CRP,creatinine,iPTH,ALP,body fat percentage and AAC score and negatively with urea clearance(P＜0.05).Multivariate Logistic regression analysis revealed that prolonged dialysis time(OR=1.758,95%CI=1.425-2.231,P＜0.001),higher AAC score(OR=2.302,95%CI=1.859-2.656,P＜0.001) and lower urea clearance(OR=1.542,95%CI=1.236-1.954,P＜0.001) were the independent risk factors for an elevated level of FABP-4.Univariate comparison showed that moderate-severe calcification group had a higher age,more diabetes and cardiovascular diseases,higher serum hs-CRP level,lower albumin level,blood calcium＞2.54 mmol/L and blood phosphorus＞1.45 mmol/L patients increasing,higher body fat percentage increased,greater statin dosing and higher level of serum FABP-4 than no-mild calcification group(P＜0.05).Spearman’s correlation analysis showed that AAC score was correlated positively with age,hs-CRP,blood calcium,blood phosphorus,body fat percentage and FABP-4(P＜0.05).Multivariate Logistic regression analysis indicated that age(OR=1.625,95%CI=1.324-2.012,P＜0.001),hs-CRP(OR=1.859,95%CI=1.526-2.235,P＜0.001),body fat percentage(OR=1.425,95%CI=1.123-1.954,P＜0.001) and FABP-4(OR=2.321,95%CI=2.012-2.654,P＜0.001) were independent risk factors for moderate-severe calcification.The receiver operating curve(ROC) revealed that the area under the curve(AUC) of serum level of FABP-4 for predicting moderate-severe calcification was 0.856 with a cutoff value of 152.3 μg/L,a sensitivity of 85.6% and a specificity of 80.9%.Conclusion Higher serum level of FABP-4 may be closely correlated with the occurrence of moderate-severe AAC in patients on maintenance PD.
    • FullText(HTML)
    • References (26)
  • [1]
    李杨,唐倩,艾利,等.急诊腹膜透析在终末期肾脏病患者中应用的Meta分析[J].临床肾脏病杂志,2021,21(6):447-454.DOI: 10.3969/j.issn.1671-2390.y20-167.

    Li Y,Tang Q,Ai L,et al.Emergency peritoneal dialysis in patients with end-stage renal disease:a Meta-analysis[J].J Clin Nephrol,2021,21(6):447-454.DOI: 10.3969/j.issn.1671-2390.y20-167.
    [2]
    任彩霞,韩昆,刘媛,等.腹膜透析患者腹主动脉钙化与外周血淋巴细胞亚群的相关研究[J].临床肾脏病杂志,2021,21(3):182-187.DOI: 10.3969/j.issn.1671-2390.y20-089.

    Ren CX,Han K,Liu Y,et al.Correlation between abdominal aortic calcification and peripheral blood lymphocyte subsets inpa-tients with peritoneal dialysis[J].J Clin Nephrol,2021,21(3):182-187.DOI: 10.3969/j.issn.1671-2390.y20-089.
    [3]
    Kim JK,Park HC,Song YR,et al.Effects of excessive body fat accumulation on long-term outcomes during peritoneal dialysis[J].Perit Dial Int,2019,39(3):268-275.DOI: 10.3747/pdi.2018.00164.
    [4]
    Lin YL,Liou HH,Lai YH,et al.Decreased serum fatty acid binding protein 4 concentrations are associated with sarcopenia in chronic hemodialysis patients[J].Clin Chimica Acta,2018,485:113-118.DOI: 10.1016/j.cca.2018.06.025.
    [5]
    Shi M,Ma L,Fu P.Role of fatty acid binding protein 4(FABP4) in kidney disease[J].Curr Med Chem,2020,27(22):3657-3664.DOI: 10.2174/0929867325666181008154622.
    [6]
    Rodríguez-Calvo R,Girona J,Alegret JM,et al.Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease[J].J Endocrinol,2017,233(3):R173-R184.DOI: 10.1530/JOE-17-0031.
    [7]
    Zhao SZ,Cao JY,Li JZ,et al.Association between serum elastin-derived peptides and abdominal aortic calcification in peritoneal dialysis patients:a cross-sectional study[J].Ren Fail,2021,43(1):860-868.DOI: 10.1080/0886022X.2021.1918163.
    [8]
    Furuhashi M.Fattyacid-binding protein 4 in cardiovascular and metabolic diseases[J].J Atheroscler Thromb,2019,26(3):216-232.DOI: 10.5551/jat.48710.
    [9]
    Hepşen S,Akhanlı P,Düǧer H,et al.Fatty acid-binding protein-4 as a biomarker predicting acromegaly-associated diabetes mellitus[J].Turk J Med Sci,2021,51(5):2592-2599.DOI: 10.3906/sag-2011-317.
    [10]
    Zhang C,Chiu KY,Chan B,et al.Knocking out or pharmaceutical inhibition of fatty acid binding protein 4(FABP4) alleviates osteoarthritis induced by high-fat diet in mice[J].Osteoarthr Cartil,2018,26(6):824-833.DOI: 10.1016/j.joca.2018.03.002.
    [11]
    Lai YH,Lin YL,Wang CH,et al.Positiveassociation of serum adipocyte fatty acid binding protein level with peripheral artery disease in hemodialysis patients[J].Ther Apher Dial,2020,24(3):300-306.DOI: 10.1111/1744-9987.13431.
    [12]
    Wang CH,Lai YH,Lin YL,et al.Increased serum leptin level predicts bone mineral density in hemodialysis patients[J].Int J Endocrinol,2020,2020:8451751.DOI: 10.1155/2020/8451751.
    [13]
    Zeng J,Sauter ER,Li B.FABP4:a new player in obesity-associated breast cancer[J].Trends Mol Med,2020,26(5):437-440.DOI: 10.1016/j.molmed.2020.03.004.
    [14]
    Rodríguez-Calvo R,Girona J,Rodríguez M,et al.Fatty acid binding protein 4(FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes[J].Metabolism,2019,96:12-21.DOI: 10.1016/j.metabol.2019.04.007.
    [15]
    Trojnar M,Patro-Małysza J,Kimber-Trojnar Z[DD(-*3]·,et al.Associations between fatty acid-binding protein 4-A proinflammatory adipokine and insulin resistance,gestational and type 2 diabetes mellitus[J].Cells,2019,8(3):227.DOI: 10.3390/cells8030227.
    [16]
    Peeters MJ,van den Brand JA,van Zuilen AD,et al.Abdominal aortic calcification in patients with CKD[J].J Nephrol,2017,30(1):109-118.DOI: 10.1007/s40620-015-0260-7.
    [17]
    Nakamura R,Okura T,Fujioka Y,et al.Serum fatty acid-binding protein 4(FABP4) concentration is associated with insulin resistance in peripheral tissues,A clinical study[J/OL].PLoS One,2017,12(6):e0179737.DOI: 10.1371/journal.pone.0179737.
    [18]
    Wang XX,Han QF,Wang T,et al.Serum albumin changes and mortality risk of peritoneal dialysis patients[J].Int Urol Nephrol,2020,52(3):565-571.DOI: 10.1007/s11255-020-02389-y.
    [19]
    周思佳,张爱华,韩庆烽.腹膜透析患者血清CHI3L1、FABP4水平和容量超负荷及蛋白质能量消耗的相关性研究[J].中国血液净化,2018,17(1):41-45,50.DOI: 10.3969/j.issn.1671-4091.2018.01.010.

    Zhou SJ,Zhang AH,Han QF.The relationships between serum CHI3L1,FABP4,volume overload and protein energy wasting in peritoneal dialysis patients[J].Chin J Blood Purif,2018,17(1):41-45,50.DOI: 10.3969/j.issn.1671-4091.2018.01.010.
    [20]
    Floresta G,Pistarà V,Amata E,et al.Adipocyte fatty acid binding protein 4(FABP4) inhibitors.A comprehensive systematic review[J].Eur J Med Chem,2017,138:854-873.DOI: 10.1016/j.ejmech.2017.07.022.
    [21]
    Furuhashi M,Sakuma I,Morimoto T,et al.Independent and distinct associations of FABP4 and FABP5 with metabolic parameters in type 2 diabetes mellitus[J].Front Endocrinol(Lausanne),2020,11:575557.DOI: 10.3389/fendo.2020.575557.
    [22]
    von Jeinsen B,Ritzen L,Vietheer J,et al.The adipokine fatty-acid binding protein 4 and cardiac remodeling[J].Cardiovasc Diabetol,2020,19(1):117.DOI: 10.1186/s12933-020-01080-x.
    [23]
    Gormez S,Erdim R,Akan G,et al.Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome[J].Cardiovasc Pathol,2020,46:107192.DOI: 10.1016/j.carpath.2019.107192.
    [24]
    Egbuche O,Biggs ML,Ix JH,et al.Fattyacid binding protein-4 and risk of cardiovascular disease:the cardiovascular health study[J].J Am Heart Assoc,2020,9(7):e014070.DOI: 10.1161/JAHA.119.014070.
    [25]
    Sung CH,Hsu BG,Tasi JP,et al.Positive associations between adipocyte fatty acid-binding protein level and central arterial stiffness in peritoneal dialysis patients[J].Int J Hypertens,2021,2021:8849115.DOI: 10.1155/2021/8849115.
    [26]
    Rodríguez-Calvo R,Moreno-Vedia J,Girona J,et al.Relationship between fatty acid binding protein 4 and liver fat in individuals at increased cardiometabolic risk[J].Front Physiol,2021,12:781789.DOI: 10.3389/fphys.2021.781789.
    • Related Articles

  • Cited by

    Periodical cited type(2)

    1. 滕健，胡艳秋，万美燕. 血清肝激酶B1水平与腹膜透析患者腹主动脉钙化的相关性研究. 中国血液净化. 2025(02): 113-117 .
    2. 曹明善，王春娣，胡小倩，孟令慧，武瑜丰，刘欢，杨华. 血清PTX3、CK-MB水平对慢性失代偿心力衰竭患者容量负荷的评估价值. 中国医师杂志. 2024(01): 87-92 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (117) PDF downloads (47) Cited by(2)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Links

    Website Copyright © Wuhan Medical and Health Association Joint Office Editorial Department of Journal of Clinical Nephrology   备案号：鄂ICP备13011742号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return